Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001062993-25-011413
Filing Date
2025-06-11
Accepted
2025-06-11 16:33:01
Documents
1
Period of Report
2025-06-09

Document Format Files

Seq Description Document Type Size
1 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES form4.html 4  
1 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES form4.xml 4 3118
  Complete submission text file 0001062993-25-011413.txt   4721
Mailing Address C/O IRONWOOD PHARMACEUTICALS, INC. 100 SUMMER STREET, SUITE 2300 BOSTON MA 02110
Business Address
McHugh Julie (Reporting) CIK: 0001487179 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36569 | Film No.: 251040507

Mailing Address 331 TREBLE COVE ROAD NORTH BILLERICA MA 01862
Business Address 331 TREBLE COVE ROAD NORTH BILLERICA MA 01862 978 671-8001
Lantheus Holdings, Inc. (Issuer) CIK: 0001521036 (see all company filings)

EIN.: 352318913 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2835 In Vitro & In Vivo Diagnostic Substances
(CF Office: 03 Life Sciences)